FDA issues guidance on alternative tools
In the guidance FDA describes use of alternative tools to assess manufacturing facilities identified in
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations